These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature. Otsubo R; Mussazhanova Z; Akazawa Y; Sato A; Matsuda K; Matsumoto M; Yano H; Matsuse M; Mitsutake N; Ando T; Niino D; Nagayasu T; Nakashima M J Pediatr Endocrinol Metab; 2018 Mar; 31(4):461-467. PubMed ID: 29427554 [TBL] [Abstract][Full Text] [Related]
26. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene. Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481 [TBL] [Abstract][Full Text] [Related]
27. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394 [TBL] [Abstract][Full Text] [Related]
28. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049 [TBL] [Abstract][Full Text] [Related]
29. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651 [TBL] [Abstract][Full Text] [Related]
30. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307 [TBL] [Abstract][Full Text] [Related]
31. Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure. Seethala RR; Chiosea SI; Liu CZ; Nikiforova M; Nikiforov YE Am J Surg Pathol; 2017 Apr; 41(4):446-457. PubMed ID: 28125451 [TBL] [Abstract][Full Text] [Related]
32. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Lannon CL; Sorensen PH Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836 [TBL] [Abstract][Full Text] [Related]
33. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616 [TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
35. Activity of Entrectinib in a Patient With the First Reported Sigal D; Tartar M; Xavier M; Bao F; Foley P; Luo D; Christiansen J; Hornby Z; Maneval EC; Multani P J Natl Compr Canc Netw; 2017 Nov; 15(11):1317-1322. PubMed ID: 29118225 [TBL] [Abstract][Full Text] [Related]
37. Prostatic adenocarcinoma with novel Yeh YA; Yang S; Constantinescu M; Chaudoir C; Tanner A; Henry M; Anderson S; Saldivar JS; Serkin F; Fazili T; Lurie AA; Yu X Am J Clin Exp Urol; 2019; 7(5):341-345. PubMed ID: 31763365 [No Abstract] [Full Text] [Related]
38. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation. Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342 [TBL] [Abstract][Full Text] [Related]
39. A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off. Reynolds S; Shaheen M; Olson G; Barry M; Wu J; Bocklage T Head Neck Pathol; 2016 Sep; 10(3):405-13. PubMed ID: 27075025 [TBL] [Abstract][Full Text] [Related]
40. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]